Results 111 to 120 of about 2,329 (147)

Drug-associated inflammatory bowel disease: a real-world pharmacovigilance study using the FAERS and JADER databases. [PDF]

Front Immunol
Ying Y, Shen M, Chen J, Feng T, Li Z, Ying Z, Yang D, Ju R, Wu J.   +8 more
europepmc   +1 more source

A real-world data analysis of Ozanimod in the FDA Adverse Event Reporting System (FAERS) database. [PDF]

Medicine (Baltimore)
Tang Q, Tang X, Hu X, Yin W, Luo L, Li Y, Zhong X.   +6 more
europepmc   +1 more source

Real-world comparison of lymphopenia profiles in S1P receptor modulators for multiple sclerosis: a multicenter retrospective study. [PDF]

J Neurol
Maniscalco GT, Sparaco M, Di Gregorio M, Cafasso G, Signoriello E, Romano F, Iodice R, Fantozzi R, Bellantonio P, Zanghi A, Sinisi L, D'Ambrosio A, Busillo V, Scarano V, Capuano R, Lavorgna L, Williams M, De Martino A, Di Battista ME, Di Giulio Cesare D, Lus G, Cassano E, Di Filippo PS, Sibilia G, Abbadessa G, Andreone V, Bonavita S.   +26 more
europepmc   +1 more source

Inflammatory bowel disease therapies and demyelinating diseases: a practical guide to therapeutic benefit and risk. [PDF]

J Crohns Colitis
Honap S, Debouverie M, Filippi M, Selchen D, Jairath V, Danese S, Peyrin-Biroulet L.   +6 more
europepmc   +1 more source

Upadacitinib Outcomes After Tofacitinib Failure in Patients With Moderate to Severe Ulcerative Colitis. [PDF]

ACG Case Rep J
Pratap K, AlBassam ABA, Narula N.
europepmc   +1 more source

Novel Autologous Regulatory T-Cell Therapy Ameliorates DSS-Induced Colitis in Humanized Mice. [PDF]

Inflamm Bowel Dis
Khan MJ, Lee YJ, Lee SY, Chung H, Nguyen-Phuong T, Kim YH, Park CG, Kang YM.   +7 more
europepmc   +1 more source

Therapeutic reactivation of hippocampal progenitors reverse cognition decline in mice with progressive brain demyelination. [PDF]

Stem Cell Reports
Nemati S, Hosseini SM, Bravo-Jimenez MA, Karimi-Abdolrezaee S.   +3 more
europepmc   +1 more source

Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trials. [PDF]

Mult Scler
Cohen JA, Arnold DL, DeLuca J, Hartung HP, Kappos L, Comi G, Selmaj K, Steinman L, Bar-Or A, Montalban X, Havrdová EK, Sheffield JK, Pachai C, Cheng CY, Riolo JV, Cree BA.   +15 more
europepmc   +1 more source

Advances in the Treatment of Ulcerative Colitis-From Conventional Therapies to Targeted Biologics and Small Molecules. [PDF]

Int J Mol Sci
Wilk A, Pawłowski M, Balcerczak E, Jeleń A, Mirowski M, Szmajda-Krygier D.   +5 more
europepmc   +1 more source

Novel Therapeutic Strategies and Biomarkers in the Management of Inflammatory Bowel Disease: A Narrative Review. [PDF]

Cureus
Kandathil Z, Raihan A, Mathanaruban T.
europepmc   +1 more source